Cerebroprotective effect of xantohumol sensu experimental stroke model: study design and preliminary results

The objective of our study was to evaluate the cerebroprotective effect of xanthohumol (ХN) on experimental models of acute ischemic stroke in vivo and in vitro. Materials and methods. We used middle cerebral artery occlusion (MCAO) and oxygen-glucose deprivation (OGD) as in vivo and in vitro models...

Full description

Saved in:
Bibliographic Details
Published inSaratov Medical Journal Vol. 2; no. 1
Main Authors Saitgareyeva, Aigul, Akhmadeyeva, Leyla
Format Journal Article
LanguageEnglish
Published 01.03.2021
Online AccessGet full text
ISSN2712-8253
2712-8253
DOI10.15275/sarmj.2021.0103

Cover

More Information
Summary:The objective of our study was to evaluate the cerebroprotective effect of xanthohumol (ХN) on experimental models of acute ischemic stroke in vivo and in vitro. Materials and methods. We used middle cerebral artery occlusion (MCAO) and oxygen-glucose deprivation (OGD) as in vivo and in vitro models. Our study subjects were Sprague-Dawley rats, which were randomly assigned to three groups: the control group and two MCAO groups with and without XN. The primary culture of cortical neurons was obtained from newborn rats. We employed the Bederson test and the corner test to evaluate neurological disorders. Results. The preliminary results indicated a possible cerebroprotective effect of XN in an ischemic stroke model. Conclusion. Preventive administration of XN before cerebral ischemia in an experiment can effectively reduce the volume of cerebral infarction and improve neurologic deficit 24 hours after MCAO.
ISSN:2712-8253
2712-8253
DOI:10.15275/sarmj.2021.0103